GENN BIOLOGICS

EUIPO EUIPO 2013 Registration expired

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark GENN BIOLOGICS was filed as Word mark on 12/23/2013 at the European Union Intellectual Property Office.
It was registered as a trademark on 07/08/2014. The current status of the mark is "Registration expired".

Trademark Details Last update: October 28, 2024

Trademark form Word mark
File reference 012461851
Application date December 23, 2013
Publication date March 31, 2014
Entry date July 8, 2014
Expiration date December 23, 2023

Trademark owner

33 Hayden Avenue
02421 Lexington
US

Trademark representatives

Nordenskiöldsgatan 11A 211 19 Malmö SE

goods and services

1 Biologic and chemical compounds for use in the manufacture of pharmaceutical preparations; active ingredients for pharmaceuticals and pharmaceutical preparations; biologic and chemical compounds being a component in pharmaceutical preparations
5 Pharmaceuticals and biologics; pharmaceuticals and biologics for treatment of rare, terminal and/or genetic diseases; pharmaceuticals and biologics for protein replacement therapies
40 Contract manufacturing in the field of pharmaceuticals and biopharmaceuticals
42 Biological, pharmaceutical and medical research; medical and scientific research, namely, conducting clinical research; laboratory research services relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical research and development; scientific and technological services, namely, biological research and analysis; research and research services in the field of the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient expression of proteins; development and research of new products for others; product development for others; providing platform technology, namely protein expression platform technology for research and development of pharmaceuticals; providing platform technology relating to protein expression platforms for manufacturing protein-based therapeutics
45 Patent licensing; licensing intellectual property

Trademark history

Date Document number Area Entry
October 25, 2024 Extension, Trade mark expired
June 15, 2022 Change Representative, Published
January 22, 2021 Change Representative, Published
January 7, 2021 Change Representative, Published
July 2, 2014 Change Representative, Published

ID: 11012461851